ATA279387A - Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung - Google Patents

Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung

Info

Publication number
ATA279387A
ATA279387A AT279387A AT279387A ATA279387A AT A279387 A ATA279387 A AT A279387A AT 279387 A AT279387 A AT 279387A AT 279387 A AT279387 A AT 279387A AT A279387 A ATA279387 A AT A279387A
Authority
AT
Austria
Prior art keywords
products containing
synergistic combination
medicinal products
phosphodiesterase inhibitor
phosphodiesterase
Prior art date
Application number
AT279387A
Other languages
English (en)
Other versions
AT393962B (de
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Priority to AT0279387A priority Critical patent/AT393962B/de
Publication of ATA279387A publication Critical patent/ATA279387A/de
Application granted granted Critical
Publication of AT393962B publication Critical patent/AT393962B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0279387A 1987-10-22 1987-10-22 Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung AT393962B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0279387A AT393962B (de) 1987-10-22 1987-10-22 Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0279387A AT393962B (de) 1987-10-22 1987-10-22 Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung

Publications (2)

Publication Number Publication Date
ATA279387A true ATA279387A (de) 1991-07-15
AT393962B AT393962B (de) 1992-01-10

Family

ID=3540382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0279387A AT393962B (de) 1987-10-22 1987-10-22 Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung

Country Status (1)

Country Link
AT (1) AT393962B (de)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77353A1 (de) * 1977-05-16 1979-01-19
DE2735830A1 (de) * 1977-08-09 1979-03-01 Thomae Gmbh Dr K Antithrombotische arzneimittelkombination und verfahren zu ihrer herstellung
US4248872A (en) * 1978-09-01 1981-02-03 Horrobin David F Method for the treatment of anxiety
DE2904736A1 (de) * 1979-02-08 1980-08-28 Thomae Gmbh Dr K Antithrombotische arzneimittelkombination
US4357330A (en) * 1981-07-30 1982-11-02 Bristol-Myers Company Pharmaceutical compositions
DE3311355A1 (de) * 1983-03-29 1984-10-04 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittel mit einer die atheroprotektiven high density lipoproteine steigernden wirkung, enthaltend 2,6-bis-diaethanolamino-4,8-dipiperidino-pyrimido (5,4-d)-pyrimidin
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3576119D1 (de) * 1984-07-21 1990-04-05 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.
US4542160A (en) * 1984-07-30 1985-09-17 E. R. Squibb & Sons, Inc. Method of use of bicycloheptane substituted prostaglandin analogs as cardiovascular agents
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3526362A1 (de) * 1985-07-19 1987-01-22 Schering Ag Prostacycline, ihre analoga oder prostaglandine und thromboxanantagonisten zur behandlung von thrombotischen und thromboembolischen krankheitsbildern

Also Published As

Publication number Publication date
AT393962B (de) 1992-01-10

Similar Documents

Publication Publication Date Title
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
FI945434L (fi) 4-markatpoasetyyliamino/2/bentsatsepinoni (3) johdannaisia ja niiden käyttö enkefalinaasi-inhibiittoreina
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
ZA845923B (en) Organic compounds and their pharmaceutical use
EP0428585A4 (en) Novel method of administering aspirin and dosage forms containing same
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
EP0304802A3 (en) Pharmaceutical composition and the use thereof
IL88159A0 (en) Salts of pentamidine and pharmaceutical compositions containing the same
DK537685D0 (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
NZ233122A (en) Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor
IL86302A0 (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
NZ216894A (en) Penicillin derivatives and pharmaceutical compositions
ZA864915B (en) Medicaments and their use
ZA869694B (en) Azoniaspironortropanol esters and their pharmaceutical use
NZ226738A (en) Ginkgolide derivatives and pharmaceutical compositions
GB2071091B (en) Acyl-derivatives of carnitine and the therapeutic use thereof
DK143188D0 (da) Farmaceutiske praeparater indeholdende pyranoquinolinforbindelser samt deres anvendelse
DE3665811D1 (en) Pharmaceutical compositions on the basis of diltiazem and aspirin
GB2209753B (en) Salts of organogermanium compounds and medicines containing the same
PH24950A (en) Pyrrolidine derivatives and pharmaceutical compositions containing the same
ZA849677B (en) Organic compounds and their pharmaceutical use
NZ216946A (en) Penicillin derivatives and pharmaceutical compositions
IT8740155A0 (it) Estensione dell'uso di un prodotto farmaceutico alimentare curativo
KR910007551B1 (en) Polyethylene terephchalate and its use
DK501588D0 (da) Phosphonater og phosphonamider samt anvendelsen heraf

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee